or
forgot password
  • cancer clinical trials in salt lake city, UT

  • Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
    Huntsman Cancer Institute At The Univ. Of Utah
    Salt Lake City, Utah 84112
    High Risk Stage III Melanoma
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    University of Utah Medical Center
    Salt Lake City, Utah 84132
    Venous Thrombosis
    Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
    University of Utah Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Bladder Cancer
    Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
    Utah Cancer Specialists at UCS Cancer Center

    Trial Locations
    Utah Cancer Specialists at UCS Cancer Center
    Huntsman Cancer Institute at University of Utah
    Esophageal Cancer
    Research Tissue Bank
    University of Utah
    Salt Lake City, Utah
    Myelofibrosis, Idiopathic Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera
    Multi-Center Project: Spinal Abnormalities in Neurofibromatosis Type1 (NF1) Patients
    Shriners Hospitals for Children, Salt Lake City
    Salt Lake City, Utah 84103
    Neurofibromatosis Type 1
    CEP-701 (Lestaurtinib) in Myelofibrosis
    University of Utah
    Salt Lake City, Utah
    Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera
    Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
    GSK Investigational Site
    Salt Lake City, Utah 84107
    Lung Cancer, Non-Small Cell
    Combination of Hydroxyurea and Verapamil for Refractory Meningiomas
    Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Cancer, Brain Cancer, Meningioma
    FDG-PET/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients
    Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Cancer
    [F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors
    Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Cancer, Brain Tumors
    A Multi-modality Imaging Assessment of Chemobrain
    Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Cancer
    Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients
    Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Cancer, Non Small Cell Lung Cancer
    Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
    Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Cancer, Chronic Myelomonocytic Leukemia
    Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer
    University of Utah School of Medicine
    Salt Lake City, Utah 84132
    Prostate Cancer
    Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes
    University of Utah
    Salt Lake City, Utah
    Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis
    Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
    Utah Cancer Specialists
    Salt Lake City, Utah 84106
    Myelogenous Leukemia, Chronic
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Huntsman Cancer Institute at University of Utah
    Salt Lake City, Utah 84112
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Primary Children's Medical Center
    Salt Lake City, Utah 84113-1100
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
    LDS Hospital
    Salt Lake City, Utah 84143
    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Acute Myelomonocytic Leukemia (M4), Childhood Anaplastic Large Cell Lymphoma, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, de Novo Myelodysplastic Syndromes, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Juvenile Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, Refractory Anemia With Ringed Sideroblasts, Refractory Chronic Lymphocytic Leukemia, Refractory Cytopenia With Multilineage Dysplasia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Splenic Marginal Zone Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Waldenström Macroglobulinemia
    FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer
    Utah Cancer Specialists

    Trial Locations
    Utah Cancer Specialists
    Utah Cancer Specialists - Salt Lake Clinic
    St. Mark's Hospital
    Utah Cancer Specialists - Salt Lake Regional
    Colorectal Cancer, Colorectal Carcinoma, Liver Metastases
    A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer
    University of Utah Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Advanced or Metastatic Solid Tumors, Advanced or Metastatic Breast Cancer
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Melanoma
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    Primary Children's Medical Center
    Salt Lake City, Utah 84113-1100
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    A Study of Nilotinib Versus Imatinib in GIST Patients
    University of Utah / Huntsman Cancer Institute Dept.ofHuntsmanCancerInst.(3)
    Salt Lake City, Utah 84112
    Gastrointestinal Stromal Tumor (GIST)
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    LDS Hospital

    Trial Locations
    LDS Hospital
    Utah Cancer Specialists at UCS Cancer Center
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer
    Utah Cancer Specialists at UCS Cancer Center
    Salt Lake City, Utah 84106
    Lung Cancer
    Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
    LDS Hospital

    Trial Locations
    LDS Hospital
    Huntsman Cancer Institute/University of Utah
    Utah Cancer Specialists-Salt Lake City
    Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Huntsman Cancer Institute/University of Utah

    Trial Locations
    Huntsman Cancer Institute/University of Utah
    Utah Cancer Specialists-Salt Lake City
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Huntsman Cancer Institute at University of Utah
    Salt Lake City, Utah 84112
    Endometrial Cancer, Fatigue, Neurotoxicity
    Multi-Tracer PET Assessment of Primary Brain Tumors
    Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Brain Tumors, Cancer
    Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
    Huntsman Cancer Institute/University of Utah
    Salt Lake City, Utah 84112
    Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Recurrent Adult Brain Tumor
    Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
    Primary Children's Medical Center
    Salt Lake City, Utah 84113-1100
    Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)
    University Health Care, 50 North Medical Drive
    Salt Lake City, Utah 84132
    Neurofibromatosis Type 1
    Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
    Huntsman Cancer Institute

    Trial Locations
    Huntsman Cancer Institute
    Utah Cancer Specialists
    Metastatic Pancreatic Cancer
    A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
    University of Utah
    Salt Lake City, Utah
    Neurofibromatosis Type 1
    Study of Immunotherapy to Treat Advanced Prostate Cancer
    Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Prostate Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    LDS Hospital

    Trial Locations
    LDS Hospital
    Utah Cancer Specialists-Salt Lake City
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer